ClinConnect ClinConnect Logo
Search / Trial NCT00442988

Prediction of NODAT After Renal Transplantation

Launched by KU LEUVEN · Mar 2, 2007

Trial Information

Current as of July 04, 2025

Completed

Keywords

Nodat Ogtt Fpg Renal Transplanation Risk Factors Predictive Value

ClinConnect Summary

All patients transplanted in our department receive a formal oral glucose tolerance test (and thus also fasting plasma glucose concentration) in the first week after renal transplantation. This testing for DM or Impaired Glucose Tolerance (IGT) is part of our standard clinical protocol and data are collected prospectively in all these patients in an electronic patient medical file. The development of diabetes mellitus in all transplant patients is documented, including DM therapy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary or secondary single kidney transplantation
  • Age older than 18 years
  • Exclusion Criteria:
  • Pre-existing DM or documented impaired glucose metabolism
  • Combined organ transplantation

About Ku Leuven

KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.

Locations

Leuven, , Belgium

Patients applied

0 patients applied

Trial Officials

Dirk R Kuypers, MD, PhD

Principal Investigator

Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials